Get the Stockscreener App
1.83
3.17%
-0.06
Brainstorm Cell Therapeutics Inc Stock (BCLI) Forecast
The Brainstorm Cell Therapeutics Inc (BCLI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.9431, representing a +115.47% increase from the current price of $1.83. The highest analyst price target is $6.974, and the lowest is $0.9121.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BCLI Price Target
Average 8.115
(+343.44% Upside)
Is Brainstorm Cell Therapeutics Inc (BCLI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.11 | Neutral |
| STOCH(9,6) | 19.16 | Buy |
| STOCHRSI(14) | 5.5357 | Buy |
| MACD(12,26) | -0.0437 | Sell |
| ADX(14) | 13.10 | Neutral |
| William %R | -80.65 | Buy |
| CCI(14) | -90.95 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.9365
Sell
|
1.9191
Sell
|
| MA20 |
2.0028
Sell
|
1.9727
Sell
|
| MA50 |
1.9281
Sell
|
2.024
Sell
|
| MA100 |
2.1155
Sell
|
2.4536
Sell
|
| MA200 |
4.017
Sell
|
3.1728
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, BCLI could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on BCLI, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.11 indicates that BCLI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 19.16 indicates that BCLI is oversold. This indicates that BCLI price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.5357 indicates that BCLI is oversold. This suggests that BCLI price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.1 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -90.95 indicates that BCLI is still oversold but not to an extreme extent.
Long-term BCLI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Brainstorm Cell Therapeutics Inc financial reports and earnings history, Brainstorm Cell Therapeutics Inc (BCLI) stock could reach $3.2546 by 2030, $0.2334 by 2040 and $5.8041 by 2050. See the projected annual prices until 2050 of the Brainstorm Cell Therapeutics Inc stock below:
- Brainstorm Cell Therapeutics Inc (BCLI) is expected to reach an average price of $1.121 in 2035, with a high prediction of $1.2945 and a low estimate of $1.1954. This indicates an $-38.74% rise from the last recorded price of $1.83.
- Brainstorm Cell Therapeutics Inc (BCLI) stock is projected to chart a bullish course in 2040, with an average price target of $0.2496, representing an $-86.36% surge from its current level. The forecast ranges from a conservative $0.4896 to a sky-high $0.2334.
- Our analysts predict Brainstorm Cell Therapeutics Inc (BCLI) to jump 0.05% by 2045, soaring from $1.7434 to an average price of $1.8308, potentially reaching $1.406. While $1.7434 is the low estimate, the potential upside is significant.
- Brainstorm Cell Therapeutics Inc (BCLI) stock is expected to climb by 2050, reaching an average of $5.3645, a $193.14% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.8041 and $5.7345, respectively, highlighting the market's uncertainty.
Brainstorm Cell Therapeutics Inc Stock (BCLI) Year by Year Forecast
Brainstorm Cell Therapeutics Inc Stock (BCLI) Price Forecast for 2025
Brainstorm Cell Therapeutics Inc Stock (BCLI) is expected to reach an average price of $7.9274 in 2025, with a high prediction of $15.32 and a low estimate of $0.537. This indicates an +333.19% rise from the last recorded price of $1.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $3.864 | $0.9121 | $6.974 | +111.15% |
| April, 2025 | $1.4973 | $1.186 | $5.7247 | -18.18% |
| May, 2025 | $3.2918 | $1.3579 | $3.4498 | +79.88% |
| June, 2025 | $2.3924 | $2.1624 | $4.5117 | +30.73% |
| July, 2025 | $7.4156 | $2.183 | $7.7156 | +305.22% |
| August, 2025 | $10.46 | $6.3962 | $10.78 | +471.48% |
| September, 2025 | $10.04 | $9.2507 | $14.43 | +448.67% |
| October, 2025 | $9.8839 | $8.6402 | $11.88 | +440.11% |
| November, 2025 | $14.27 | $9.4496 | $14.43 | +679.59% |
| December, 2025 | $7.4297 | $6.0991 | $15.32 | +306.00% |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Price Forecast for 2026
The predicted value for Brainstorm Cell Therapeutics Inc (BCLI) in 2026 is set at an average of $5.435. Estimates vary from a peak of $10.23 to a trough of $0.639, indicating an +196.99% surge from the present price of $1.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.6923 | $1.2317 | $10.23 | +47.12% |
| February, 2026 | $2.7849 | $1.9742 | $3.3542 | +52.18% |
| March, 2026 | $2.6274 | $1.8761 | $2.9155 | +43.58% |
| April, 2026 | $4.4806 | $2.6281 | $5.6994 | +144.84% |
| May, 2026 | $1.7932 | $0.7019 | $2.6313 | -2.01% |
| June, 2026 | $1.3158 | $1.1045 | $2.3839 | -28.10% |
| July, 2026 | $1.099 | $0.639 | $1.5577 | -39.95% |
| August, 2026 | $1.7116 | $0.9796 | $1.9015 | -6.47% |
| September, 2026 | $1.2948 | $1.1248 | $1.9035 | -29.25% |
| October, 2026 | $1.8173 | $1.0361 | $2.067 | -0.69% |
| November, 2026 | $1.3699 | $1.1186 | $1.848 | -25.14% |
| December, 2026 | $1.2231 | $1.0418 | $1.7318 | -33.16% |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Brainstorm Cell Therapeutics Inc (BCLI) is $1.6858, with a high forecast of $2.5728 and a low forecast of $0.7989. This indicates an -7.88% decrease from the last price of $1.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0557 | $1.0084 | $1.2744 | -42.31% |
| February, 2027 | $0.9483 | $0.8163 | $1.3383 | -48.18% |
| March, 2027 | $1.5215 | $0.7989 | $2.2715 | -16.86% |
| April, 2027 | $1.684 | $1.4121 | $2.5728 | -7.98% |
| May, 2027 | $1.2866 | $0.9053 | $1.6747 | -29.69% |
| June, 2027 | $1.1898 | $1.0585 | $1.4972 | -34.98% |
| July, 2027 | $1.6324 | $1.1205 | $1.7524 | -10.80% |
| August, 2027 | $1.405 | $1.355 | $1.9337 | -23.23% |
| September, 2027 | $1.3482 | $0.9969 | $1.6662 | -26.33% |
| October, 2027 | $1.3007 | $1.1107 | $1.4501 | -28.92% |
| November, 2027 | $1.2633 | $1.082 | $1.4014 | -30.97% |
| December, 2027 | $2.0065 | $1.0052 | $2.0465 | +9.65% |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Price Forecast for 2028
In 2028, Brainstorm Cell Therapeutics Inc (BCLI) is projected to reach an average price of $1.6483, with a high projection of $3.2172 and a low estimate of $0.0794. This indicates an -9.93% fall from the last price of $1.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.8991 | $1.6672 | $3.2172 | +3.77% |
| February, 2028 | $3.0116 | $1.6597 | $3.1516 | +64.57% |
| March, 2028 | $2.2049 | $1.6536 | $3.0823 | +20.48% |
| April, 2028 | $0.3874 | $0.1274 | $2.3023 | -78.83% |
| May, 2028 | $0.4406 | $0.0794 | $0.8306 | -75.92% |
| June, 2028 | $0.3032 | $0.1305 | $0.5325 | -83.43% |
| July, 2028 | $1.7458 | $0.1941 | $1.7758 | -4.60% |
| August, 2028 | $0.499 | $0.299 | $1.8364 | -72.73% |
| September, 2028 | $1.7316 | $0.3496 | $2.3709 | -5.38% |
| October, 2028 | $1.9541 | $1.4448 | $2.3265 | +6.78% |
| November, 2028 | $2.0573 | $1.5067 | $2.186 | +12.42% |
| December, 2028 | $1.1199 | $1.0393 | $2.368 | -38.80% |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Price Forecast for 2029
The 2029 price forecast for Brainstorm Cell Therapeutics Inc Stock (BCLI) is $1.4811 on average, with a high prediction of $2.951 and a low estimate of $0.0111. This represents an -19.07% decrease from the previous price of $1.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.9531 | $0.5825 | $1.2035 | -47.92% |
| February, 2029 | $0.8157 | $0.545 | $1.0238 | -55.43% |
| March, 2029 | $0.1625 | $0.1489 | $0.9763 | -91.12% |
| April, 2029 | $0.5892 | $0.0111 | $0.5822 | -67.80% |
| May, 2029 | $0.5356 | $0.5556 | $0.5673 | -70.73% |
| June, 2029 | $0.4034 | $0.424 | $0.4853 | -77.96% |
| July, 2029 | $0.3478 | $0.4183 | $0.4021 | -80.99% |
| August, 2029 | $0.2143 | $0.2575 | $0.3102 | -88.29% |
| September, 2029 | $0.1761 | $0.2229 | $0.147 | -90.38% |
| October, 2029 | $0.0982 | $0.1467 | $0.1379 | -94.64% |
| November, 2029 | $0.1027 | $0.0207 | $0.3315 | -94.39% |
| December, 2029 | $3.081 | $0.0168 | $2.951 | +68.36% |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Price Forecast for 2030
Brainstorm Cell Therapeutics Inc Stock (BCLI) is expected to reach an average price of $2.0281 in 2030, with a high forecast of $3.9481 and a low forecast of $0.1081. This signifies an +10.82% surge from the last price of $1.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.2846 | $3.2397 | $3.2546 | +79.49% |
| February, 2030 | $2.3794 | $2.7094 | $3.0133 | +30.02% |
| March, 2030 | $3.0543 | $2.8382 | $2.7543 | +66.90% |
| April, 2030 | $2.9392 | $3.0392 | $2.9405 | +60.61% |
| May, 2030 | $2.7127 | $2.6866 | $2.5876 | +48.24% |
| June, 2030 | $2.8026 | $2.6689 | $2.6015 | +53.15% |
| July, 2030 | $2.4532 | $2.7212 | $2.685 | +34.05% |
| August, 2030 | $2.586 | $2.4099 | $2.406 | +41.31% |
| September, 2030 | $1.8509 | $1.9509 | $2.1405 | +1.14% |
| October, 2030 | $0.9135 | $1.8645 | $1.9308 | -50.08% |
| November, 2030 | $0.3894 | $0.1081 | $3.9481 | -78.72% |
| December, 2030 | $1.3242 | $1.5368 | $1.1042 | -27.64% |
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):